Status:
COMPLETED
Time To Efficacy and Onset Of Action Of Linezolid
Lead Sponsor:
Pfizer
Conditions:
Gram-Positive Bacterial Infections
Skin and Connective Tissue Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To assess the onset of action of linezolid
Eligibility Criteria
Inclusion
- suspected grampositive infection
- fever \> 38 C
Exclusion
- Infections to be treated successfully by surgical procedures
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT00147511
Start Date
June 1 2003
End Date
June 1 2005
Last Update
May 10 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.